Skip to main content
icon for 2026年には、ニューヨーク市の住民の間で西ナイル神経侵襲性疾患の症例が何件報告される予定ですか?

2026年には、ニューヨーク市の住民の間で西ナイル神経侵襲性疾患の症例が何件報告される予定ですか?

icon for 2026年には、ニューヨーク市の住民の間で西ナイル神経侵襲性疾患の症例が何件報告される予定ですか?

2026年には、ニューヨーク市の住民の間で西ナイル神経侵襲性疾患の症例が何件報告される予定ですか?

20件未満 43%

20から34 39%

35~49 16%

50例以上 7%

Polymarket
新規

20件未満 43%

20から34 39%

35~49 16%

50例以上 7%

Polymarket
新規

20件未満

$750 Vol.

43%

20から34

$637 Vol.

39%

35~49

$1,386 Vol.

16%

50例以上

$262 Vol.

7%

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.Elevated West Nile virus detection in over 1,284 mosquito pools across all NYC boroughs—nearly double the prior year’s pace—drives trader focus on transmission risk through late summer and early fall. Only one neuroinvasive disease case has been confirmed among residents as of mid-August, consistent with typical onset patterns but well below recent annual averages of 25–31 cases. Warmer temperatures and precipitation patterns have expanded mosquito breeding and viral amplification in Culex vectors, while intensified surveillance, larviciding, and public advisories introduce uncertainty about final totals. Historical variability in case counts, combined with the remaining peak transmission window and potential underreporting of milder infections, keeps market-implied probabilities closely split between fewer than 20 and 20–34 cases.

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.

Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.

The 2026 count shown on the source as of January 1, 2027 is the starting figure.

If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.

If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
音量
$3,034
終了日
2027/03/31
マーケット開始日
Aug 20, 2026, 5:18 PM ET
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.Elevated West Nile virus detection in over 1,284 mosquito pools across all NYC boroughs—nearly double the prior year’s pace—drives trader focus on transmission risk through late summer and early fall. Only one neuroinvasive disease case has been confirmed among residents as of mid-August, consistent with typical onset patterns but well below recent annual averages of 25–31 cases. Warmer temperatures and precipitation patterns have expanded mosquito breeding and viral amplification in Culex vectors, while intensified surveillance, larviciding, and public advisories introduce uncertainty about final totals. Historical variability in case counts, combined with the remaining peak transmission window and potential underreporting of milder infections, keeps market-implied probabilities closely split between fewer than 20 and 20–34 cases.

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.

Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.

The 2026 count shown on the source as of January 1, 2027 is the starting figure.

If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.

If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
音量
$3,034
終了日
2027/03/31
マーケット開始日
Aug 20, 2026, 5:18 PM ET
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.

外部リンクに注意してください。

よくある質問

「2026年には、ニューヨーク市の住民の間で西ナイル神経侵襲性疾患の症例が何件報告される予定ですか?」はPolymarket上の4個の結果が可能な予測市場で、トレーダーが何が起こるかに基づいてシェアを売買します。現在のリード結果は「20件未満」で43%、次いで「20から34」が39%です。価格はコミュニティのリアルタイム確率を反映しています。例えば、43¢で取引されているシェアは、市場がその結果に43%の確率を集合的に割り当てていることを意味します。これらのオッズは継続的に変化します。正しい結果のシェアは市場決済時に各$1で引き換え可能です。

「2026年には、ニューヨーク市の住民の間で西ナイル神経侵襲性疾患の症例が何件報告される予定ですか?」はPolymarket上で新しく作成された市場です(Aug 20, 2026開始)。早期の市場として、最初のトレーダーの一人としてオッズを設定し、市場の初期価格シグナルを確立するチャンスです。このページをブックマークして、取引量と活動を追跡することもできます。

「2026年には、ニューヨーク市の住民の間で西ナイル神経侵襲性疾患の症例が何件報告される予定ですか?」で取引するには、このページに記載されている4個の利用可能な結果を閲覧します。各結果には市場の暗示確率を表す現在の価格が表示されています。ポジションを取るには、最も可能性が高いと思う結果を選び、「はい」で支持するか「いいえ」で反対するかを選択し、金額を入力して「取引」をクリックします。選んだ結果が市場決済時に正しければ、「はい」のシェアは各$1を支払います。正しくなければ$0です。決済前にいつでもシェアを売却できます。

「2026年には、ニューヨーク市の住民の間で西ナイル神経侵襲性疾患の症例が何件報告される予定ですか?」の現在のフロントランナーは「20件未満」で43%であり、市場がこの結果に43%の確率を割り当てていることを意味します。次に近い結果は「20から34」で39%です。これらのオッズはトレーダーがシェアを売買するにつれてリアルタイムで更新されます。頻繁に確認するか、このページをブックマークしてください。

「2026年には、ニューヨーク市の住民の間で西ナイル神経侵襲性疾患の症例が何件報告される予定ですか?」の決済ルールは、各結果が勝者と宣言されるために何が起こる必要があるかを正確に定義しています。これには結果を決定するために使用される公式データソースも含まれます。このページのコメント上にある「ルール」セクションで完全な決済基準を確認できます。取引前にルールを注意深く読むことをお勧めします。